AP1189
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AP1189, covering 2023-11-07 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria [Phase 2]